A multi-layered film preparation

Abstract: A multi-layered film preparation has a drug containing layer which contains a water-soluble high molecular weight substance as a main base material, has on one surface thereof a layer difficult to dissolve in water, and carries on the other surface an adhesive substance or contains therein the adhesive substance in a dispersed state. The film preparation is easy in handling thereof and shows good adhesiveness to the mucous membrane in the oral cavity, even if it has been remarkably moisted, and gives no bad feeling in use.

Description: The present invention relates to a multi-layered film for pain-killing, protecting or treating an affected part of the mucous membrane in the oral cavity and more particularly, to that improved in handling thereof. Hitherto, many proposals have been made on a preparation to be applied on an affected part of the mucous membrane, and more particularly to that in oral cavity. An adhesive preparation was disclosed in Jap. Pat. No. 54 - 41320 (A) which comprises a compact mixture or composition to be adhered on mucous membrane in the oral cavity and containing hydroxypropylcellulose, polyacrylic acid or a salt thereof as well as a drug or effective ingredient agent. This preparation has been formed by tabletting granular or powder-form ingredients, hasa thickness of lmm or more, and is poor in flexibility. Therefore, such a preparation gives a certain malaise to a patient, when it has been adhered on mucous membrane in the oral cavity, and possibly causes pain. For improving such a feeling in use and sustaining the power in effect, then various films have been studied having a layer difficult to dissolve in water (non-adhesive layer), as disclosed in Jap. Pat. Nos. 63-18923(B), 58 - 128314(A), 58 - 213709(A), 2 - 60644(B), and 62 - 56420(A). These films solve the feeling in use and sustaining the power in effect, but show such a disadvantage that the force of adhesion becomes low, as the degree of moisture in the area of mucous membrane (affected part) is higher. In order to dissolve the problem, investigations have been made on various adhesive base materials and a combination thereof, as disclosed in Jap. Pat. Nos. 62 - 135417(A), 3 - 33215(B), 6 - 2669(B), 6 - 2670(B), 3-246220(A), and 4 - 266819(A). The amount of the adhesive base material to be composed has also been investigated, but a preparation improved in both of the adhesive force and feeling in use has not yet been developed, since the feeling in use becomes worse due to stickiness, as the amount thereof increases. A double-layered film consisting of a drug containing layer and a non-water soluble layer (non-adhesive layer) has been investigated, since in case of applying an adhesive preparation to an affected part in a narrow space as in a oral cavity, the film tends to stick to the fingers, or slips-off from the affected part. Moreover, triple layered films having an adhesive layer in addition to said layers have also been investigated in order to increase the force of adhesion to the mucous membrane in the oral cavity. Such a film shows a sufficient force of adhesion, if the moisture of the mucous membrane in the oral cavity is not so high as in a healthy person. However, it does not show a sufficient force of adhesion, when an affected part is in highly moist state due to an erosion caused by an infectional disease or a side effect through a radiotherapy and/or chemotherapy, so that falling off the affected part or getting out of its position due to slipping can not be prevented. An object of the present invention is to provide a multi-layered film which shows excellent adhesion to an affected part of the mucous membrane in the oral cavity, even if it has been remarkably moisted. Followings are relations between objects and means for attaining the objects. Object : To improve handling of the film for preventing adhesion of the film to the fingers and to prevent slipping of the film from the affected part to muscous membrane neighboring thereto. Means therefor. : To make the film as a triple-layered one consisting of an adhesive layer comprising an adhesive substance in the form of powder, an intermediate layer (a drug containing layer) and a layer made difficult to dissolve in water (non-adhesive layer), or as a double-layered one consisting of the adhesive layer comprising an adhesive substance in the form of powder (drug containing layer) and the layer made difficult to dissolve in water. Object : To keep a sufficient force of adhesion, even if an affected part is remarkably moisted and prevent slipping-off therefrom. Means therefor : To select a powder of an adhesive high molecular weight substance for forming the adhesive layer, or disperse such a powder in the drug containing layer. According to this means, adhesiveness of the film to mucous membrane can remarkably be improved in comparison with a conventional film, wherein an adhesive high molecular weight substance is made into a form of film. Therefore, a multi-layered film according to the present invention is characterized by having a drug containing layer which contains a water-soluble high molecular weight substance as a main base material, a non-adhesive layer which is made difficult to dissolve in water and is positioned on one of both surfaces of the drug containing layer, and an adhesive layer comprising an adhesive substance in the form o powder positioned on the other surface of the drug containing layer. Otherwise, a multi-layered film according to the present invention is characterized by having a drug containing layer, in which an adhesive high molecular weight substance in the form of powder is dispersed, and a non-adhesive layer which is made difficult to dissolve in water and positioned on one of both surfaces of the drug containing layer. Identifications between said adhesive layer and said layer made difficult to dissolve in water as well as between said layer made difficult to dissolve in water and said drug containing layer are possible by tactile sense and sense of eyesight. For increasing the force of adhesion, it is convenient to apply the high molecular weight substance or a gum in the form of a powder on the adhesive layer, add the powder into the adhesive layer, or disperse the powder in the adhesive layer, although a conventional film has been formed by dissolving the high molecular weight substance or gum into a solvent, pouring the solution into a mold, and then evaporating the solvent. As the water-soluble high molecular weight substance to be employed as the main base material for the film according to the present invention, e.g. the following compounds can be listed: water-soluble cellulose derivatives [hydroxypropylcellulose (HPC), hydroxypropylmethylcellulose (HPMC), methylcellulose (MC), carboxymethylcellulose (CMC) and a salt thereof], polyvinyl alcohol, polyethylene oxide and the like, which may be used solely or in a combination thereof. Among them, the hydroxypropylcellulose (HPC) is most preferable, since it is excellent in formability of a soft film. As an agent for making the layer difficult to dissolve in water, e.g. the following compounds can be listed: shellac, stearic acid, palmitic acid and the like higher fatty acid; ethylcellulose, cellulose acetate, cellulose butyrate and the like cellulose derivatives having a low solubility to water; hydroxypropyl cellulose phthalate, acetic cellulose phthalate and the like enteric film forming agents. A good layer has been formed in case of using a combination of shellac and HPC, ethylcellulose and HPC as well as using solely the enteric film forming agent. As an adhesive substance, e.g. the following compounds can be listed: carboxyvinylpolymer, sodium polyacrylate and the like polyacrylic acid derivatives and their pharmaceutically acceptable non-toxic salts; a copolymer of acrylic acid and its pharmaceutically acceptable non-toxic salts; carboxymethylcellulose, sodium carboxymethylcellulose and the like hydrophilic cellulose derivatives; pullulan, povidone, karaya gum, pectin, xanthane gum, tragacanth, alginic acid, gum arabic, acidic polysaccharide and its derivatives as well as its non-toxic salts. Particularly, carboxyvinylpolymer, sodium polyacrylic acid, pectin and karaya gum were excellent adhesion, when such a substance was applied on the drug containing layer or added therein, in a form of powder. There is no limitation in the preparation of the adhesive layer, if it can keep the state of powder and can be applied on or dispersed in the drug containing layer in a uniform state. Generally, following methods can be listed for forming the adhesive layer. (1) By the way for removing a solvent from the drug containing layer, the adhesive high molecular weight substance in the form of powder is applied on the drug containing layer. (2) The adhesive high molecular weight substance in the form of powder is applied on the drug containing layer, a solution of a water-soluble high molecular substance is sprayed thereon, and then dried. (3) To the surface of the drug containing layer, a suspension of the adhesive high molecular weight substance in a solvent which can dissolve the base material of the drug containing layer, or in a solution of the water-soluble high molecular weight substance is applied, and then dried. (4) A suspension of the adhesive high molecular weight substance in a solution containing the water-soluble high molecular weight substance and drug is poured on a teflon (trademark) plate, and then the solvent therein is removed. Various drugs may be applied to the film according to the invention such as a local anesthetic agent, analgesical-anti-inflammatoric agent, hemo- static agent, steroid agent, fungicide, antiviral agent, antibiotic, and synthetic antibacterial agent. As the local anesthesias, e.g. the following compounds can be listed: tetracaine, diethylaminoethyl p-butylaminobenzoate, oxybuprocaine, lidocaine, dibucaine, propytocaine, and salts thereof. As the analgesical-anti-inflammatorical agents, e.g. the following compounds can be listed: aspirin, ace- * toaminophen, acemethacine, ibuprofen, indomethacin, ketoprofen, flurbiprofen, glycyrrhizic acid, fulufenamic acid, phenylbutazone, naproxen, oxyhenbutazone, diclofenac sodium, benzydamine, mepirizole, isothipendyl hydrochloride, bufexamac, bendazac, azulene, piroxicam, diflunisal, and the like. As the anti-inflammatorical steroid, e.g. the following compounds can be listed: triamcinolone acetonide, dexamethazone, hydrocortisone acetate, fluocinolone acetonide, dexamethazone acetate, prednisolone, betamethasone valerate, prednisolone valerate, beclometasone dipropionate, and the like. As the hemostaics, e.g. the following compounds can be listed: carbazochrome, thrombin, tranexamic acid, and the like. As the fungicides, e.g. the following compounds can be listed: miconazol, amphotericin B, nystatin, griseofulvin, and the like. As the antiviral agents, e.g. the following compounds can be listed: aciclovir, vidarabine, and the like. As the antibiotics, e.g. the following compounds can be listed: penicillin, gentamicin, fladiomicin, cefalexin, phosphomycin, erythromycin, chloramphenicol, tetracycline, and the like. As the synthetic antibacterial agents, e.g. the following compounds can be listed: ciprofloxacin, fleroxacin, thiamphenicol, and the like. Such a drug can be employed solely or in a combination thereof. By taking into consideration a pollution at the affected part by bacteria or the like, a bactericide (iodo, povidone iodo or the like) can be added into the drug containing layer or adhesive layer. For the film according to the invention, if necessary, an additive such as a plasticizer, corrective, coloring agent and the like can be added to each layer, in addition to said base material and drug. As the plasticizer to give softness, e.g. the following compounds can be listed: polyethyleneglycol ("Macrogol", trademark), propyleneglycol, glycerin, medium chain-length triglyceride (MCT), a copolymer of ethylene oxide and propylene oxide, triacetin, polysorbate, triethyl citrate, lauric acid, sucrose, sorbitol, phthalic acid ester and the like. Among them, it is preferable to use polyethyleneglycol, when hydroxypropylcellulose (PHC) is selected as the water-soluble high molecular weight substance. As the corrective, e.g. the following compounds can be listed: citric acid, tartaric acid, fumaric acid and the like organic acids; saccharin, glycyrrhizic acid, sucrose, frucrtose, mannitol and the like sweetening agents; menthol, mentha harb oil and the like refrigerants; a natural and synthetic spices; an edible lake and the coloring agent. Preferably the multi-layered film further comprises two releasing papers adhered on one of both surfaces of said film, one of which covers a part of the film and the other of which covers the remaining part of the films, and both of which overlap with each other. In another embodiment, the multi-layered film further comprises a releasing paper which is adhered on one of both surfaces of said film to cover the same and has a tab-like portion extending outside of the film. The invention will now be further explained in more detail with reference to Manufacturing Examples, Reference Examples and Test Examples which shall refer to drawings, in which Fig. 1 is a side view showing a first embodiment of a film according to the invention, which has a releasing paper on one of surfaces thereof; Fig. 2 is a plan view of the first embodiment shown in Fig. 1 ; Fig. 3 is is a side view showing a second embodiment of a film according to the invention, which has a releasing paper on one of the surfaces thereof ; Fig. 4 is a plan view of the second embodiment shown in Fig. 3 ; 1 Fig. 5 is a side view showing a third embodiment of a film according to the invention, which has two releasing papers on one surface ; Fig. 6 is a plan view of the third embodiment shown in Fig. 5 ; Fig. 7 is a diagrammatic illustration showing a machine which measures an adhesive force of the film : Fig. 8 is a graph showing results of a test for measuring the adhesive force of the film ; and Fig. 9 is a graph showing results of a test for measuring an amount of adsorbed water. Example 1 Formation of adhesive layer by powder applying method (1) A homogeneous solution of hydroxypropylcellulose (1007mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (20mg), lidocaine hydrochloride (107mg) in ethanol (37ml) was poured into a teflon coated petri dish (diameter : 10cm) and the solution was gradually dried to obtain a drug containing layer in the dish. Then, a solution of hydroxypropylcellulose (86mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C )), polyethyleneglycol 400 (48mg) and refined shellac (43mg) in ethanol (6ml) was sprayed on the drug containing layer, and then dried. The spraying and drying procedures were repeated to obtain a double-layered film in the petri dish. The double-layered film was peeled off from the petri dish and then placed again in the petri dish, so that the drug containing layer directs upward. Carboxyvinyl polymer (190mg, 100 mesh pass, containing 0.5% polyacrylic acid, viscosity : 29400 - 39400cps as aqueous solution of sodium salt and having pH of 7.0 - 7.5) was suspended in a solution containing hydroxypropyl cellulose (54mg, viscosity : 150-400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (1mg) and dichloromethane (25ml) to spray the homogeneous suspension on the drug containing layer and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 1 Formation of adhesive layer by solution applying method (1) . A double-layered film consisting of a drug containing layer and alayer made difficult to dissolve in water was prepared as described in Example 1. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A solution of hydroxypropylcellulose (54mg, viscosity : 150 - 400cps as 2% aqueous at 20°C), carboxyvinylpolymer (190mg, polyacrylic acid 0.5%, viscosity : 29400-39400cps as aqueous solution of pH 7.0 - 7.5 sodium salt) and polyetyhle-neglycol 400 (1mg) in 50% ethanol solution (50ml) was sprayed on the drug containing layer in the petri dish, and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 2 Formation of adhesive layer by powder applying method (2) A double-layered film consisting of a drug containing layer and a layer made difficult to dissolve in water was prepared as described in Example 1. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A powder of carboxyvinylpolymer (190mg, 100 mesh pass, polyacrylic acid 0.5%, viscosity : 45000-80000cps as aqueous solution of sodium salt and having pH of 7.0 - 7.5) was applied uniformly on the drug containing layer. Further, a solution of hydroxypropylcellulose (54mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C) and polyethyleneglycol 400 (1mg) in ethanol (10ml) was sprayed on the surface of carboxyvinylpolymer and dried to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 2 Formation of adhesive layer by solution applying method (2) A double-layered film consisting of a drug containing layer and alayer made difficult to dissolve in water was prepared as described in Example 2. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A solution of carboxyvinylpolymer (190mg, polyacrylic acid 0.5%, viscosity : 45000- 80000cps as aqueous solution of sodium salt and having pH of 7.0 - 7.5) and polyethyleneglycol 400 (4mg) in 50% ethanol solution (50ml) was sprayed on the drug containing layer in the petri dish, and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 3 Formation of adhesive layer by powder applying method (3) A homogeneous solution of hydroxypropylcellulose (503mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), hydroxypropylmethylcellulose 2208 (503mg, viscosity : 4100 - 5600cps as 1% aqueous solution at 20°C ), polyethyleneglycol 400 (30mg), tetracaine hydrochloride (18mg) in 50% ethanol solution (56ml) was poured into a teflon coated petri dish (diameter : 10cm), and solution was gradually dried to obtain a drug containing layer. A solution of hydroxypropylcellulose (86mg, viscosity : 150- 400cps as 2% aqueous solution at 20°C ) , polyethyleneglycol 400 (48mg) and stearic acid (43mg) in 50% ethanol solution was poured into the petri dish and on the drug containing layer for gradually drying the solution to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A powder of sodium polyacrylate (190mg, 100 mesh pass, viscosity : 200- 350cps as 2% aqueous solution at 20°C ) was uniformly suspended in a solution of hydroxypropylcellulose (54mg, viscosity : 150-400cps as 2% aqueous solution at 20°C ) and polysolvate 80 (2mg) in a mixture of ethanol and dichloromethane (1 : 1, 54mg). The suspension was sprayed on the drug containing layer in the petri dish and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 3 Formation of adhesive layer by solution applying method (3) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 3. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A solution of hydroxypropylcellulose (54mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), sodium polyacrylate (190mg, viscosity : 200 - 350cps as 0.2% aqueous solution at 20°C ) and glycerine (25mg) in 20% ethanol solution (40ml) was sprayed on the drug containing layer in the petri dish and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 4 Formation of adhesive layer by powder applying method (4) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 3. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. The surface of the drug containing layer was moisted and dissolved by spraying ethanol solution, and a powder of sodium polyacrylate (190mg, 100 mesh pass, vicosity : 400 - 600cps as 0.2% aqueous solution at 20°C ) was applied on the surface of the drug containing layer and dried to obtain a double-layered film consisting of the drug containing layer having the adhesive high molecular weight substance powders on outer surface thereof and layer made difficult to dissolve in water. Comparative Example 4 Formation of adhesive layer by solution applying method (4) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 4. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of sodium polyacrylate (190mg, viscosity : 400 - 600cps as 0.2% aqueous solution at 20°C ) and D-sorbitol (lOmg) in 20% ethanol solution (40ml) was poured into the petri dish and on the drug containing layer. The solution in the petri dish was gradually dried. The partial pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 5 Formation of adhesive layer by powder applying method (5) A homogeneous solution of hydroxypropylcellulose (1007mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (20mg), dibucaine hydrochloride (9mg) in ethanol solution (37ml) was poured into a teflon coated petri dish (diameter : 10cm), and the solution was gradually dried to obtain a drug containing layer. A solution of hydroxypropylcellulose (86mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (48mg) and palmitic acid (43mg) in ethanol solution (9ml) was poured into the petri dish and on the drug containing layer, and the solution was gradually dried to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The double-layered film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A powder of povidone (190mg, PVP K90, 100 mesh pass, viscosity : 300 - 700cps as 10% aqueous solution) was applied on the drug containing layer in the petri dish. Then, a solution of hydroxypropylcellulose (40mg, viscosity : 1000 - 4000cps as 2% aqueous solution at 20°C ) ) and polyethyleneglycol 400 was sprayed on the drug containing layer in the petri dish and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 5 Formation of adhesive layer by solution applying method (5) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 3. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of povidone (190mg, PVP K90, viscosity : 300 - 700cps as 10% aqueous solution) and polyethyleneglycol 400 (8mg) in ethanol (40ml) was poured into the petri dish and on the drug containing layer, and dried. The pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 6 Formation of adhesive layer by powder applying method (6) Hydroxypropylcellulose (503mg, viscosity : 1000 - 4000cps as 2% aqueous solution at 20°C ), hydroxypropylcellulose (503mg, viscosity : 150-400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (2mg) and lidocaine hydrochloride (107mg) were added into ethanol solution (37ml) to stir for obtaining a homogeneous solution, and then pullulan (190mg) was added thereto to prepare a suspension. The suspension was poured into a teflon coated petri dish (diameter : 10cm) and gradually dried the same to obtain a drug containing layer, in which particles of pullulan was uniformly dispersed. A part of solution of hydroxypropylmethylcellulose phthalate 220731 (86mg) and polyethyleneglycol 400 (9mg) in a mixture of ethanol and methylene chloride (1 : 1, 9ml) was sprayed on the surface of the drug containing layer in the petri dish. The spraying and drying procedures were repeated to obtain a double-layered film consisting of the drug containing layer, on which particles of the adhesive high molecular substance appear and layer made difficult to dissolve in water. Comparative Example 6 Formation of adhesive layer by solution applying method (6) A homogeneous solution of hydroxypropylcellulose (503mg, viscosity : 1000 - 4000cps as 2% aqueous solution at 20°C ), hydroxypropylcellulose (503mg, viscosity : 150 -400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (20mg) and lidocaine hydrochloride (107mg) in ethanol solution (37ml) was poured into a teflon coated petri dish (diameter : 10cm), and the solution was gradually dried to obtain a drug containing layer. A solution of hydroxypropylmethylcellulose phthalate 220731 (86mg) and polyethyleneglycol 400 (9mg) in a mixture of ethanol and methylene chloride (1 : 1, 9ml) was sprayed on the surface of the drug containing layer in the petri dish and dried. The spraying and drying procedures were repeated to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of pullulan (190mg) and glycerine (19mg) in water (25ml) was poured into the petori dish and on the drug containing layer, and dried. The pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 7 Formation of adhesive layer by powder applying method (7) A homogeneous solution of hydroxypropylcellulose (503mg, viscosity : 1000 - 4000 as 2% aqueous solution at 20°C ), methylcellulose (503mg, viscosity : 7000 - 10000cps as 2% aqueous solution at 20°C ), glycerine (20mg) and dibucaine hydrochloride (9mg) in 70% ethanol solution (56ml) was poured into a teflon coated petri dish (diameter : 10cm), and the solution was gradually dried to obtain a drug containing layer. A part of solution of hydroxypropylcellulose (86mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (48mg) and refined shellac (43mg) in ethanol (5.9ml) was poured into the petri dish and on the drug containing layer and gradually dried to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The double-layered film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. The outer surface of drug containing layer was moisted by spraying 10% ethanol solution, and then a powder of sodium carboxymethylcellulose (190mg, 100 mesh pass, viscosity : 1000 - 1400cps as 1% aqueous solution at 25°C ) was applied on the drug containing layer in the petri dish and dried to obtain a double-layered film consisting of the drug containing layer with the adhesive high molecular weight substance powders at its outer surface and layer made difficult to dissolve in water. Comparative Example 7 Formation of adhesive layer by solution applying method (7) A double-layered film was prepared as described in Example 7. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of sodium carboxymethylcellulose (190mg, viscosity : 1000 - 1400cps as 1% aqueous solution at 25°C ), glycerine (9mg) in 10% ethanol solution (40ml) was poured into the petri dish and on the drug containing layer and dried. The pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 8 Formation of adhesive layer by powder applying method (8) A homogeneous solution of hydroxypropylcellulose (503mg, viscosity : 1000 - 4000cps as 2% aqueous solution at 20°C ), methylcellulose (viscosity of the 2% solution is 7000 - 10000cps at 20°C ), glycerine (20mg) and dibucaine hydrochloride (9mg) in 70% ethanol solution (56ml) was poured into a teflon coated petri dish (diameter : 10cm), and the petri dish was left to stand. At the time when the content in the petri dish was somewhat dried, a powder of sodium carboxymethylcellulose (190mg, 100 mesh pass, viscosity : 6500 - 8000cps as 1% aqueous solution at 20°C ) was uniformly sprayed on the content in the petri dish, and then dried on the whole to obtain a drug containing layer with the adhesive high molecular weight substance on one surface thereof. The drug containing layer was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A solution of hydroxypropylcellulose (86mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (48mg) and refined shellac (43mg) in ethanol (5.9ml) was poured into the petri dish, and the solution was gradually dried to obtain a double-layered film consisting of the drug containing layer with the adhesive high molecular weight substance thereon and layer made difficult to dissolve in water. Comparative Example 8 Formation of adhesive layer by solution applying method (8) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 7. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of sodium carboxymethylcellulose (190mg, viscosity : 6500 - 8000cps as 1% aqueous solution at 25°C ) and glycerine (20mg) in 10% ethanol solution (40ml) was poured into the petri dish and on the drug containing layer and gradually dried. The pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 9 Formation of adhesive layer by powder applying method (9) A homogeneous solution of hydroxypropylcellulose (1007mg, viscosity : 150 - 400 as 2% aqueous solution at 20°C ) 503mg, polyethyleneglycol 400 (20mg) and dibucaine hydrochloride (9mg) in ethanol (37ml) was poured into a teflon coated petri dish (diameter : 10cm), and the solution was gradually dried to obtain a drug containing layer. A part of solution of hydroxypropylcellulose (86mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (48mg) and refined shellac (43mg) in ethanol (5.9ml) was sprayed on the drug containing layer and then dried. The spraying and drying procedures were repeated to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The double-layered film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. On the outer surface of drug containing layer, pectin (190mg) was uniformly applied. A solution of hydroxypropylcellulose (40mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ) and polyethyleneglycol 400 (0.8mg) in ethanol (15ml) was sprayed on the pectin layer and dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 9 Formation of adhesive layer by solution applying method (9) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 9. The film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of pectin (190mg), hydroxypropylcellulose (18mg, viscosity 150 - 400cps as 2% aqueous solution at 20°C ) and polyethyleneglycol 400 (6mg) in water (50ml) was sprayed on the drug containing layer in the petri dish, and then dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 10 Formation of adhesive layer by powder applying method (10) A homogeneous solution of polyvinylalcohol (partially saponificated substance, 1007mg, viscosity : 40 - 50cps as 4% aqueous solution at 20°C ), glycerin (30mg) and dibucaine hydrochloride (18mg) in water (25ml) was poured into a teflon coated petri dish (diameter : 10cm) and the solution was gradually dried to obtain a drug containing layer. A suspension was prepared by dissolving hydroxypropylmethylcellulose acetate succinate (86mg) and triethyl citrate (18mg) into a mixture of ethanol and methylenechloride (1 : 1, 9ml), adding thereto titanium oxide (0.4mg), and then stirring on the whole. A part of the suspension was sprayed on the drug containing layer in the petri dish and dried. The spraying and drying procedures were repeated to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. The double-layered film was peeled-off from the petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A suspension was prepared by dissolving hydroxypropylcellulose (54mg, viscosity : 6 - 10cps as 2% aqueous solution at 20°C ) and polysolvate 80 (10mg, trademark) in a mixture of ethanol and dichloromethane (1 : 1, 20ml), and uniformly dispersing thereto karaya gum (190mg) and lake aluminum (Yellow No. 5, 0.4mg). The suspension was poured into the petri dish and on the drug containing layer and dried to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 10 Formation of adhesive layer by solution applying method (10) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 10. The double-layered film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A suspension was prepared by dissolving karaya gum (190mg), hydroxypropylcellulose (18mg, viscosity : 6 - lOcps as 2% aqueous solution at 20°C ) and polyethyleneglycol 400 (6mg) in 10% ethanol solution (50ml), and then uniformly dispersing lake aluminum (Yellow No. 5, 0.4mg). The suspension was poured into the petri dish and on the drug containing layer and dried in vacuo, and the pouring and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 11 Formation of adhesive layer by solution applying method (11) A double-layered film consisting of a drug containing layer and layer made difficult to dissolve in water was prepared as described in Example 1. The double-layered film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of hydroxypropylcellulose (54mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), carboxyvinylpolymer (410mg, polyacrylic acid : 0.5%, viscosity : 29400 - 39400cps as aqueous solution of sodium salt and having pH of pH 7.0 - 7.5) and polyethylene glycol 400 (10mg) in 50% ethanol solution (100ml) was sprayed on the drug containing layer in the petri dish, and then dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Comparative Example 12 Formation of adhesive layer by solution applying method (12) A double-layered film consisting of a drug containing. layer and layer made difficult to dissolve in water was prepared as described in Example 7. The double-layered film was peeled-off from a teflon coated petri dish, and then turned over and placed again in the petri dish, so that the drug containing layer directs upward. A part of solution of sodium carboxymethylcellulose (570mg, viscosity : 1000- 1400cps as 1% aqueous solution at 25°C ) and glycerine (27mg) in 10% ethanol solution (40ml) was poured into the petri dish and on the drug containing layer, and the solution was gradually dried. The spraying and drying procedures were repeated to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 11 Formation of adhesive layer by application machine A homogeneous solution was prepared by dissolving hydroxypropylcellulose (329mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), ethylcellulose (329mg) and polyethyleneglycol 400 (243mg) were into ethanol (7.2ml) and the solution was charged into an application machine (Type YBA applicator and manufactured by Baker Instruments Corp.) to develop the same having a size of 20 x 20cm 2 and thickness of 187 µm and dried to obtain a layer made difficult to dissolve in water. A solution of hydroxypropylcellulose (5468mg, viscosity : 150 - 400cps as 2% aqueous solution at 20°C ), polyethyleneglycol 400 (109mg) and dibucaine hydrochloride (100mg) in ethanol (121ml) was applied on the said layer in in thickness of 600µ m and then dried. The procedures of applying the drug containing solution and drying were repeated 8 times to obtain a double-layered film consisting of the drug containing layer and layer made difficult to dissolve in water. Hydroxypropylcellulose (268mg, viscosity : 150 - 400cps as 2% solution at 20°C ) and polyethyleneglycol 400 (946mg), were dissolved in ethanol (9ml) and then pectin (946mg) was uniformly dispersed therein to prepare a suspension. The suspension was applied on the drug containing layer of double-layered film, in thickness of 450 µm and dried to obtain a triple-layered film consisting of the adhesive layer, drug containing layer and layer made difficult to dissolve in water. Example 12 Manufacture of film containing anti-inflammatoric and analgesic agent By treating as described in Example 11, except that diclofenac sodium (lOOmg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 13 Manufacture of film containing anti-inflammatoric and analgesic agent By treating as described in Example 11, except that sodium difrunisal (500mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 14 Manufacture of film containing anti-inflammatoric steroid By treating as described in Example 11, except that triamcinolone acetonide (5mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 15 Manufacture of film containing hemostatic agent By treating as described in Example 11, except that tranexamic acid (100mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 16 Manufacture of film containing fungicide By treating as described in Example 11, except that amphotericin B (100mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 17 Manufacture of film containing an fungicide By treating as described in Example 11, except that nystatin (300mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 18 Manufacture of film containing antiviral agent By treating as described in Example 11, except that vidarabine (300mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 19 Manufacture of film containing antiviral agent By treating as described in Example 11, except that aciclovir (500mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 20 Manufacture of film containing antibiotic By treating as described in Example 11, except that chloramphenicol (100mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 21 Manufacture of film containing antibiotic By treating as described in Example 11, except that fradiomycin sulfate (50mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 22 Manufacture of film containing synthetic antibacterial drug By treating as described in Example 11, except that thiamphenicol (50mg) was selected instead of dibucaine hydrochloride to obtain a triple-layered film. Example 23 Manufacture of film containing a mixture of drugs By treating as described in Example 11, except that thimphenicol (50mg) was added in addition to dibucaine hydrochloride (100mg) to obtain a triple-layered film. Example 24 Manufacture of film containing a mixture of drugs By treating as described in Example 11, except that miconazole nitrate (39mg), chloramphenicol palmitate (50mg), dexamethasone (2mg) and guaiazulene (6mg) were added in addition to dibucaine hydrochloride (100mg) to obtain a triple-layered film. Test Example 1 (Evaluation of adhesion) Each of the films obtained by Examples and "Waplon P" (exemplary known film, trademark) were selected as Test Films and Control Film, and a force of adhesion thereof was evaluated. However, the test was carried out under 2 different conditions, since it has been supposed that mucous membrane in the oral cavity was somewhat dry or moist condition. The moist condition was set by gargling with 100ml of water just before the test. The evaluation was given by a panel of healthy persons (10 members) based on following standards. Score The contents of evaluation 1 Enable to apply steadly on mucous membrane in oral cavity and do not come off by movement of mucous membrane (expansion and contraction) after applied thereon and do not move easily by a tongue. 2 Enable to apply steadly on mucous membrane in oral cavity. Do not come off by movement of cheek, but it moves by force of tongue. 3 Enable to come off easily, or cannot be applied on mucous membrane in oral cavity. Results of the test are shown in following Table 1. As apparently seen therefrom, all of the films including test and control ones show good force of adhesion, when the mucous membrane is in dry state, but in moist state, the films obtained by Examples 1 - 10 show better results in comparison with the films obtained by Comparative Examples 1 - 10 as well as control film. Particularly, excellent adhesion has been obtained, when carboxyvinylpolymer or pectin were used as a base material. Films Base of the adhesive layer (viscosity) Result of evaluation (ave. of score) wet state dry state Example 1 carboxyvinylpolymer (29400 - 39400cps) 1.2 1.0 Comp. Ex. 1 2.4 1.0 Example 2 carboxyvinylpolymer (45000 - 80000cps) 1.0 1.0 Comp. Ex. 2 2.1 1.0 Example 3 sodium polyacrylic acid (200 - 350cps) 2.2 1.5 Comp. Ex. 3 3.0 1.5 Example 4 sodium polyacrylic acid (400 - 600cps) 2.1 1.2 Comp. Ex. 4 3.0 1.4 Example 5 povidone (300 - 700cps) 1.6 1.3 Comp. Ex. 5 2.9 1.6 Example 6 pullulan (300 - 700cps) 1.5 1.4 Comp. Ex. 6 3.0 1.2 Example 7 sodium carboxymethylcellulose (1000 - 1400cps) 1.6 1.2 Comp. Ex. 7 2.7 1.5 Example 8 sodium carboxymethylcellulose (6500 - 8000cps) 1.5 1.2 Comp. Ex. 8 2.8 1.4 Example 9 pectin 1.2 1.3 Comp. Ex. 9 3.0 1.2 Example 10 karaya gum 1.4 1.3 Comp. Ex. 10 2.8 1.4 Waplon P 3.0 1.1 In the table, Example : powder applying method, Comp. Ex. : solution applying method. Test Example 2 (Evaluation on feeling in use) Feeling in use was checked between films obtained by Example 1 and Comparative Example 11 as well as Examples 7 and Comparative Example 12 by a panel of 5 healthy persons. In connection with this, it had previously been confirmed that the force of adhesion of the films obtained by Example 1 and Comparative Example 11 as well as Example 7 and Comparative Example 12 are substantially same, respectively, in case of those shall be applied on mucous membrane in oral cavity, in moist state. Results are shown in following Table 2. It suggests that the films obtained by Comparative Examples gives highly sticky feeling and are not preferable than those obtained by Examples. In other words, such a fact has been confirmed that a film, in which an amount of added adhesive material is lesser, gives better feeling in use, if films have same force of adhesion. Feeling in use after lapsed 1 hour Number of panelist Ex. 1 Comp. Ex. 11 Ex. 7 Comp. Ex. 12 No problem 0 0 0 0 There is sticky feeling in applied part, but can bear 5 1 4 1 There is sticky feeling in applied part, feel displeasure 0 3 1 4 There is sticky feeling in applied part, but cannot bear 0 1 0 0 Test Example 3 (Identification of adhesive layer and non-adhesive layer) An identification test on adhesive layer and non-adhesive layer have been carried out with use of films obtained by Examples 1 and 10, Comparative Examples 1 and 10 as well as "Waplon P" (exemplary known film , trademark) and by a panel of 10 persons of 60 years old or more. The test was carried out by 3 times to each sample to avoid a possible misjudgement. Each of the films obtained by Example 10 and Comparative Example 10 as well as Waplon P has been colored to make easy identification of its adhesive layer by eyesight. While, the films obtained by Examples 1 and 10 have been manufactured by the powder application method and thus there is given a possibility for identifying the adhesive layer by a tactile sense. Results are shown in following Table 3. It is apparent therefrom that the films obtained by Examples 1 and 10 are excellent. Film Coloring Number of distinguished persons among 10 panelists Perfect Less than 2 times Example 1 No 8 2 Example 10 Yes 9 1 Comp.Ex. 1 No 1 9 Comp.Ex. 10 Yes 4 6 Waplon P Yes 5 5 Test Example 4 (Evaluation on feeling in taking out from packed film) The film obtained by Example 2 was cut into pieces 1 having a square form and a releasing paper 2 was adhered on the adhesive layer of each piece, in various manner as shown in Figs. 1 - 6 and packed in a package of aluminum foil to make Test Films A - C. The Test Films A, B and C are shown in Figs. 1 and 2, 3 and 4 as well as 5 and 6, respectively. The test was carried out with use of the Test Films A - C and Waplon P as a control and by 10 old persons having 60 years or more evaluation thereof had been given under following standards. Score 1 : Easy to peel off the releasing paper from the film, Score 2 : Difficult to peel off the releasing paper from the film, Score 3 : Very difficult to peel off the releasing paper from the film , and Score 4 : Impossible to peel off the releasing paper from the film. Results are in following Table 4. Film Average of Score Test Film A 3.8 B 2.2 C 1.6 Waplon P 2.9 Test Example 5 (Evaluation on force of adhesion) A force of adhesion of the film obtained by Examples 1 and 11 (with powdered adhesive high molecular weight substance) and a conventional film obtained by Comparative Examples 1 and 9 (the adhesive high molecular weight substance is dissolved and dried to prepare a film-like state) was compared with use of a rheometer 10 as shown in Fig. 7. Namely, non-adhesive surface of the film 1 was adhered to an adapter 11 of a disc having a diameter of 2cm and the adapter was set to the rheometer 10. A bakelite plate 12 was placed on a sample table 13 and a carboxymethylcellulose (CMC) membrane 3 was placed thereon. Just after dropping 10 µl of water on the CMC membrane, the sample stand 13 was moved upwardly to press the film between the CMC membrane and adapter by a force of 1000g for 60 seconds. Then, the sample plate was moved downwardly by 10mm/min to cause a peeling off of the film from the sample table, so as to measure a force of adhesion of the film. The test was carried out by 3 times on each test film. Results are shown in following Table 5. As apparently seen therefrom, the force of adhesion of the film according to the invention is higher than that of the conventional film with a significant difference. Film Adhesive substance Force of adhesion (g) Average Standard deviation Example 1 carboxyvinylpolymer 729.7 115.7 Com. Ex. 1 carboxyvinylpolymer 238.0 23.5 Example 11 pectin 468.7 73.9 Com. Ex. 9 pectin 290.0 30.8 In the Table, Example : powder-applying method, Comparative Example : solution-splaying method. Test Example 6 (Test on absorption of water) An absorptive power of water of an adhesive high molecular weight substance in powder state and film state was compared by a tea bag method and sheet methods which are simple methods on absorptive power of water regarding general high molecular weight substances and described in "manufacture of functional polymer gel and its application", edited by Masahiro Irie, CMC Co. Ltd., 1987). Firstly, a solution of carboxyvinyl polymer (190mg) in ethanol (lOml) was poured into a  10cm petri dish and gradually dried to obtain a film. Similarly, a pectin film was obtained by using the a pectin (190mg) and water (20ml). On a tape with an adhesive layer on both surfaces which was adhered and carried on a polyvinyl chloride (PVC) film (thickness : 200µ m, surface area 2 x 2cm 2 ), a powder of a high molecular weight substance (10mg) or said film was applied and then the free surface of the PVC film was fixed on one end of a horizontal propeller, each of which wings has a length of 4cm and width of 2cm. Thereafter, 1 ml of water was dropped on the powder layer or said film and left to stand for a constant period of time (10, 30, 60 and 120 seconds) and then the propeller was rotated for 10 seconds at 500rpm to remove excess moisture. By measuring weight of the propeller to check weight of water absorbed by the powder or film of high molecular weight substance. The procedure was repeated by 3 times to calculate an amount of water (mg) per unit time (1 second) and unit weight (lmg of the substance). For a compensation, similar procedure was carried out on the PVC film per se having no adhesive substance in the form of powder or film. Results are shown in following Table 6. As apparently seen therefrom that an adsorption efficiency of carboxyvinyl polymer and pectin in the form of powder is higher with a significant difference than that in film state. Especially, an amount of absorbed water in case of the powder state and lapsing time of 10 seconds is remarkably high and this estimate that the film having the adhesive substance in the form of powder rapidly absorbs the moisture from an affected part and expands to develop an excellent force of adhesion. Adhesive substance Form Time (sec) Water absorption speed (mg/sec/mg) Average Standard deviation Carboxyvinyl polymer powder 10 1.005 0.131 30 0.451 0.106 60 0.224 0.051 120 0.117 0.006 Carboxyvinyl polymer film 10 0.157 0.008 30 0.132 0.024 60 0.078 0.019 120 0.042 0.017 Pectin powder 10 0.651 0.094 30 0.329 0.023 60 0.175 0.018 120 0.083 0.011 Pectin film 10 0.248 0.067 30 0.038 0.012 60 0.025 0.004 120 0.009 0.002

Claims: A multi-layered film comprising a drug-containing layer which contains a water-soluble high molecular weight substance as a main base material, a non-adhesive layer which is made difficult to dissolve in water and positioned on one of both surfaces of said drug containing layer, and an adhesive substance in the form of powder and positioned on the other surface of said drug containing layer. The multi-layered film as claimed in Claim 1, wherein said adhesive substance in the form of powder is forming an adhesive layer. A multi-layered film comprising a drug containing layer which contains a water-soluble high molecular weight substance as a main base material, a non-adhesive layer which is made difficult to dissolve in water and positioned on one of both surfaces of said drug containing layer, and an adhesive substance in the form of powder and dispersed in the drug containing layer. The multi-layered film as claimed in any one of Claims 1 - 3, wherein said non-adhesive layer made difficult to dissolve in water contains at least one of the material selected from the group consisting of shellac, higher fatty acid, cellulose derivative having low solubility to water and enteric film forming agent. The multi-layered film as claimed any one of Claims 1-4, wherein said water-soluble substance is at least one of materials selected from the group consisting of hydroxypropylcellulose hydroxypropylmethylcellulose, methylcellulose, carboxymethylcellulose, and a salt thereof: polyvinylalcohol: and polyethylene oxide. The multi-layered film as claimed in any one of Claims 1 - 5, wherein said adhesive substance is at least one of materials selected from the group consisting of carbooxyvinylpolymer, polyacrylic acid derivatives and their pharmaceutically acceptable non-toxic salts, acrylic acid copolymers and their pharmaceutically acceptable non-toxic salts, carboxymethylcellulose, hydrophilic cellulose derivatives, pullulan, povidone, karaya gum, pectin, xan- thane gum, tragacanth, alginic acid, gum arabic, acidic polysaccharide and its derivatives as well as its non-toxic salts. The multi-layered film as claimed in any one of Claims 1 - 6which is applied to the mucous membrane in the oral cavity. The multi-layered film as claimed in any one of Claims 1 - 7 wherein said drug containing layer comprises at least one of the drugs selected from the goup consisting of a local anesthetic agent, analgesical-anti-inflammatorical agent, steroid, hemos- tatic agent, fungicide, antiviral agent, antibiotic and synthetic antibacterial agent. The multi-layered film as claimed in Claim 1, 2. 3. 4, 7 or 8, for use in curing an erosion of the mucous membrane in the oral cavity, due to a side effect of a radiotherapy. and chemotherapy as well as an infection disease.

Inventors: NAGAO YOSHIYUKI, SATO YUJI, SUGIMOTO MANABU, TOMIYA NOBORU, USAMI MAKOTO, YAMAMURA KEIKO, NAGAO, YOSHIYUKI, SATO, YUJI, SUGIMOTO, MANABU, TOMIYA, NOBORU, USAMI, MAKOTO, YAMAMURA, KEIKO
Applicants: SANWA KAGAKU KENKYUSHO CO, SANWA KAGAKU KENKYUSHO CO., LTD.
Application year: 1996
Main classification: A61K9
IPC codes: A61P1, A61K47, A61P25, A61K31, A61P31, A61K45, A61K9, A61P17, A61P29, A61P7